1-6 of 6
Huiqin Chen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Differential Efficacy of Bevacizumab and Erlotinib in Preclinical Models of Renal Medullary Carcinoma and Fumarate Hydratase-Deficient Renal Cell Carcinoma.

Available to Purchase
Niki M. Zacharias, Manuel Ozambela, Menuka Karki, Rong He, Pankaj K. Chauhan, Pedro I. Pesquera, Andres E. Hernandez Gonzalez, Oscar Ochoa, Alberto Pieretti, Huiqin Chen, Carolyn De La Cerda, Zhiyuan Yu, Abha Grover, Samantha Hicks-Peña, Natalie W. Fowlkes, Lei Wang, Tapati Maity, Priya Rao, Giannicola Genovese, Nizar M. Tannir, Jose A. Karam, Pavlos Msaouel
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2025)
https://doi.org/10.1158/1535-7163.MCT-24-0703
Published: 02 July 2025
View articletitled, Differential Efficacy of Bevacizumab and Erlotinib in Preclinical Models of Renal Medullary Carcinoma and Fumarate Hydratase-Deficient Renal Cell Carcinoma.
Open the PDF for Differential Efficacy of Bevacizumab and Erlotinib in Preclinical Models of Renal Medullary Carcinoma and Fumarate Hydratase-Deficient Renal Cell Carcinoma. in another window
Includes: Supplementary data
Journal Articles

Assessment of Patient-Derived Xenograft Growth and Antitumor Activity: The NCI PDXNet Consensus Recommendations

Open Access
Funda Meric-Bernstam, Michael W. Lloyd, Soner Koc, Yvonne A. Evrard, Lisa M. McShane, Michael T. Lewis, Kurt W. Evans, Dali Li, Lawrence Rubinstein, Alana Welm, Dennis A. Dean, II, Anuj Srivastava, Jeffrey W. Grover, Min J. Ha, Huiqin Chen, Xuelin Huang, Kaushik Varadarajan, Jing Wang, Jack A. Roth, Bryan Welm, Ramaswamy Govinden, Li Ding, Salma Kaochar, Nicholas Mitsiades, Luis Carvajal-Carmona, Meenhard Herylyn, Michael A. Davies, Geoffrey I. Shapiro, Ryan Fields, Jose G. Trevino, Joshua C. Harrell, NCI PDXNet Consortium, James H. Doroshow, Jeffrey H. Chuang, Jeffrey A. Moscow
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2024) 23 (7): 924–938.
https://doi.org/10.1158/1535-7163.MCT-23-0471
Published: 02 July 2024
View articletitled, Assessment of Patient-Derived Xenograft Growth and Antitumor Activity: The NCI PDXNet Consensus Recommendations
Open the PDF for Assessment of Patient-Derived Xenograft Growth and Antitumor Activity: The NCI PDXNet Consensus Recommendations in another window
Includes: Supplementary data
Journal Articles

Abstract P058: Anti-tumor activity of ATR inhibitor BAY 1895344 in patient-derived xenograft (PDX) models with DNA damage response (DDR) pathway alterations

Free
Christian X. Cruz Pico, Dali Li, Christopher D. Lanier, Kurt Evans, Maria G. Raso, Timothy DiPeri, Yasmeen Rizvi, Min Jin Ha, Huiqin Chen, Ming Zhao, Argun Akcakanat, Xiaofeng Zheng, Gokce Toruner, Erkan Yuca, Stephen Scott, Antje M. Wengner, Timothy A. Yap, Funda Meric-Bernstam
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2021) 20 (12_Supplement): P058.
https://doi.org/10.1158/1535-7163.TARG-21-P058
Published: 01 December 2021
View articletitled, Abstract P058: Anti-tumor activity of ATR inhibitor BAY 1895344 in patient-derived xenograft (PDX) models with DNA damage response (DDR) pathway alterations
Journal Articles

Cooperative Effect of Oncogenic MET and PIK3CA in an HGF-Dominant Environment in Breast Cancer

Free
Shuying Liu, Shunqiang Li, Bailiang Wang, Wenbin Liu, Mihai Gagea, Huiqin Chen, Joohyuk Sohn, Napa Parinyanitikul, Tina Primeau, Kim-Anh Do, George F. Vande Woude, John Mendelsohn, Naoto T. Ueno, Gordon B. Mills, Debu Tripathy, Ana M. Gonzalez-Angulo
Journal: Molecular Cancer Therapeutics
Series: Author Choice
Mol Cancer Ther (2019) 18 (2): 399–412.
https://doi.org/10.1158/1535-7163.MCT-18-0710
Published: 04 February 2019
View articletitled, Cooperative Effect of Oncogenic MET and PIK3CA in an HGF-Dominant Environment in Breast Cancer
Open the PDF for Cooperative Effect of Oncogenic MET and PIK3CA in an HGF-Dominant Environment in Breast Cancer in another window
Includes: Supplementary data
Journal Articles

PI3K Pathway Mutations and PTEN Levels in Primary and Metastatic Breast Cancer

Free
Ana M. Gonzalez-Angulo, Jaime Ferrer-Lozano, Katherine Stemke-Hale, Aysegul Sahin, Shuying Liu, Juan A. Barrera, Octavio Burgues, Ana M. Lluch, Huiqin Chen, Gabriel N. Hortobagyi, Gordon B. Mills, Funda Meric-Bernstam
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2011) 10 (6): 1093–1101.
https://doi.org/10.1158/1535-7163.MCT-10-1089
Published: 08 June 2011
View articletitled, PI3K Pathway Mutations and PTEN Levels in Primary and Metastatic Breast Cancer
Open the PDF for PI3K Pathway Mutations and PTEN Levels in Primary and Metastatic Breast Cancer in another window
Journal Articles

Rapamycin Regulates Stearoyl CoA Desaturase 1 Expression in Breast Cancer

Free
David Luyimbazi, Argun Akcakanat, Priscilla F. McAuliffe, Li Zhang, Gopal Singh, Ana Maria Gonzalez-Angulo, Huiqin Chen, Kim-Anh Do, Yuhuan Zheng, Mien-Chie Hung, Gordon B. Mills, Funda Meric-Bernstam
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2010) 9 (10): 2770–2784.
https://doi.org/10.1158/1535-7163.MCT-09-0980
Published: 10 October 2010
View articletitled, Rapamycin Regulates Stearoyl CoA Desaturase 1 Expression in Breast Cancer
Open the PDF for Rapamycin Regulates Stearoyl CoA Desaturase 1 Expression in Breast Cancer in another window
Includes: Supplementary data